Crystal structure of zwitterionic 3-(2-hydroxy-2-phosphonato-2-phosphonoethyl)imidazo[1,2-a]pyridin-1-ium monohydrate (minodronic acid monohydrate): a redetermination
In a previous study, the X-ray structure of the title compound, C9H12N2O7P2·H2O, was reported [Takeuchi et al., (1998). Chem. Pharm. Bull. 46, 1703–1709], but neither atomic coordinates nor details of the geometry were published. The structure has been redetermined with high precision as its detaile...
Main Authors: | Annalisa Airoldi, Piergiorgio Bettoni, Monica Donnola, Gianluca Calestani, Corrado Rizzoli |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union of Crystallography
2015-01-01
|
Series: | Acta Crystallographica Section E: Crystallographic Communications |
Subjects: | |
Online Access: | http://scripts.iucr.org/cgi-bin/paper?S2056989014026863 |
Similar Items
-
Minodronate for the treatment of osteoporosis
by: Ohishi T, et al.
Published: (2018-04-01) -
A review of minodronic acid hydrate for the treatment of osteoporosis
by: Tanishima S, et al.
Published: (2013-02-01) -
Potassium tetracyanidoaurate(III) monohydrate: a redetermination
by: Nobuyuki Matsushita, et al.
Published: (2017-03-01) -
Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01) -
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
by: Mizue Tanaka, et al.
Published: (2017-03-01)